Organon

Organon is a global healthcare company formed through a spinoff from Merck (known as MSD outside of the U.S. and Canada) with a mission to deliver impactful medicines and solutions for a healthier every day. We build upon our strong foundation of more than 60 medicines and other products across a range of areas including reproductive health, heart disease, dermatology, allergies and asthma.

We bring these important therapies around the world, with an international footprint that serves people in more than 140 markets.  We believe the diversity of our business provides a sustainable engine of growth so we can continue to invest in and advance new medicines and treatments for women that are so urgently needed.

We are here for her health.

< Back to AmChams

Latest Content

February 29, 2024
AACCLA Raises Pillar One Implementation Concerns with OECD

AACCLA wrote to the OECD’s Centre for Tax Policy and Administration to express concerns about local implementation challenge...

Read more
November 2, 2023
Forecast on Latin America and the Caribbean Conference: What You Need to Know

The U.S. Chamber’s Association of American Chambers of Commerce in Latin America and the Caribbean (AACCLA) is hosting its annua...

Read more
November 2, 2023
Inter-American Development Bank “BID for the Americas” Program Launch Remarks

U.S. Chamber of Commerce President and CEO Suzanne P. Clark gave the following remarks at the Inter-American Development Bank “B...

Read more